Weight-loss treatments have quickly emerged as one of the hottest areas for R&D in the pharmaceutical industry. The rapidly realized blockbuster sales of the leading drugs in the space, Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, means there is a strong interest in the pipeline of follow-on and next-generation drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,